|
09 Mar 2017
|
Omkar Speciality
|
Rudra Shares and Stock Brokers Ltd
|
5.70
|
180.00
|
156.20
(-96.35%)
|
Target met |
Buy
|
|
|
Company is focusing on the backward and forward integration to add value to its operations and yield better performance, enabling company to become cost competitive. This is giving the cost benefits not only by reducing cost of the intermediates, which otherwise it would have purchased from the market, but also enhance margins on APIs that are developed by using these in-house manufactured intermediates. This initiative by the Company will go a long way in improving its EBITDA margins and net profits of the Company and provide a strong foundation to its operations....
|
|
27 Oct 2015
|
Omkar Speciality
|
BOB Capital Markets Ltd.
|
5.70
|
267.00
|
225.25
(-97.47%)
|
|
Buy
|
|
|
Omkar Speciality Chemicals Q2FY16 Result Review
Omkar Speciality Chemicals has posted strong consolidated revenues of Rs. 1bn implying 52%/12% YoY/QoQ growth during Q2FY16. The EBITDA margin has contracted by 192 bps/ 107bps to 18% from...
|
|
22 Jul 2015
|
Omkar Speciality
|
BOB Capital Markets Ltd.
|
5.70
|
265.00
|
175.75
(-96.76%)
|
|
Buy
|
|
|
Omkar Speciality Chemicals Q1FY16 Result
Omkar Speciality Chemicals has declared robust financial results for Q1FY16 with a consolidated PAT growth of 64% to Rs. 82mn vs Rs. 50mn in Q1FY15. It has reported robust YoY consolidated revenues...
|
|
16 Jun 2015
|
Omkar Speciality
|
BOB Capital Markets Ltd.
|
5.70
|
156.00
|
155.65
(-96.34%)
|
Target met |
Buy
|
|
|
Omkar Speciality Chemcials Q4FY5 Result Update
Omkar Speciality Chemicals reported flat YoY consolidated revenues of Rs.739mn and grew by 4.2% QoQ in Q4FY15. The EBITDA margin has expanded by 338 bps YoY to 19% from 15.6% led by decline in...
|
|
04 Feb 2015
|
Omkar Speciality
|
BOB Capital Markets Ltd.
|
5.70
|
287.00
|
166.35
(-96.57%)
|
|
Buy
|
|
|
Omkar Speciality Chemicals Research Report
|